These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2724077)

  • 1. Kinetics of aluminum in rats I: Dose-dependent elimination from blood after intravenous administration.
    Pai SM; Melethil S
    J Pharm Sci; 1989 Mar; 78(3):200-2. PubMed ID: 2724077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of aluminum in rats. III: Effect of route of administration.
    Xu ZX; Tang JP; Badr M; Melethil S
    J Pharm Sci; 1992 Feb; 81(2):160-3. PubMed ID: 1545356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption and disposition of aluminum in the rat.
    Gupta SK; Waters DH; Gwilt PR
    J Pharm Sci; 1986 Jun; 75(6):586-9. PubMed ID: 3735104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose toxicokinetics of aluminum in the rat.
    Wilhelm M; Zhang XJ; Hafner D; Ohnesorge FK
    Arch Toxicol; 1992; 66(10):700-5. PubMed ID: 1290402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of renal impairment, chemical form, and serum protein binding on intravenous and oral aluminum kinetics in the rabbit.
    Yokel RA; McNamara PJ
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):32-43. PubMed ID: 3413794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of aluminum in rats. IV: Blood and cerebrospinal fluid kinetics.
    Xu ZC; Tang JP; Xu ZX; Melethil S
    Toxicol Lett; 1992 Oct; 63(1):7-12. PubMed ID: 1412525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aluminium toxicokinetics after intramuscular, subcutaneous, and intravenous injection of Al citrate solution in rats.
    Weisser K; Göen T; Oduro JD; Wangorsch G; Hanschmann KO; Keller-Stanislawski B
    Arch Toxicol; 2019 Jan; 93(1):37-47. PubMed ID: 30302509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aluminum bioavailability and disposition in adult and immature rabbits.
    Yokel RA; McNamara PJ
    Toxicol Appl Pharmacol; 1985 Feb; 77(2):344-52. PubMed ID: 3975904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of aluminum in rats. II: Dose-dependent urinary and biliary excretion.
    Xu ZX; Pai SM; Melethil S
    J Pharm Sci; 1991 Oct; 80(10):946-51. PubMed ID: 1784003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminum distribution into brain and liver of rats and rabbits following intravenous aluminum lactate or citrate: a microdialysis study.
    Yokel RA; Lidums V; McNamara PJ; Ungerstedt U
    Toxicol Appl Pharmacol; 1991 Jan; 107(1):153-63. PubMed ID: 1987654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entry, half-life, and desferrioxamine-accelerated clearance of brain aluminum after a single (26)Al exposure.
    Yokel RA; Rhineheimer SS; Sharma P; Elmore D; McNamara PJ
    Toxicol Sci; 2001 Nov; 64(1):77-82. PubMed ID: 11606803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation, elimination, and effects of parenteral exposure to aluminum in newborn and adult rats.
    Veiga M; Bohrer D; Banderó CR; Oliveira SM; do Nascimento PC; Mattiazzi P; Mello CF; Lenz QF; Oliveira MS
    J Inorg Biochem; 2013 Nov; 128():215-20. PubMed ID: 23916521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentachlorophenol toxicokinetics after intravenous and oral administration to rat.
    Reigner BG; Gungon RA; Hoag MK; Tozer TN
    Xenobiotica; 1991 Dec; 21(12):1547-58. PubMed ID: 1785202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of solubility on the gastrointestinal absorption of aluminum from various aluminum compounds in the rat.
    Froment DH; Buddington B; Miller NL; Alfrey AC
    J Lab Clin Med; 1989 Sep; 114(3):237-42. PubMed ID: 2769017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerator mass spectrometry: application to study of aluminum kinetics in the rat.
    Meirav O; Sutton RA; Fink D; Middleton R; Klein J; Walker VR; Halabe A; Vetterli D; Johnson RR
    Am J Physiol; 1991 Mar; 260(3 Pt 2):F466-9. PubMed ID: 2000958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of HI-6 oxime in rats after intravenous and intramuscular administration.
    Simons KJ; Briggs CJ
    J Pharm Pharmacol; 1985 May; 37(5):367-9. PubMed ID: 2862253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of aluminum from drinking water.
    Fulton B; Jaw S; Jeffery EH
    Fundam Appl Toxicol; 1989 Jan; 12(1):144-50. PubMed ID: 2925013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of aluminum 3-hydroxypyridin-4-one complexes: implications for aluminum redistribution subsequent to chelation therapy.
    Allen DD; Orvig C; Yokel RA
    Toxicology; 1994 Sep; 92(1-3):193-202. PubMed ID: 7940560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Absorption, distribution, and excretion of arbekacin after intravenous and intramuscular administration in rats].
    Mitomi N; Matsumoto T; Fujigaki M; Komiya I; Kai F
    Jpn J Antibiot; 1987 Feb; 40(2):357-64. PubMed ID: 3599384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lethality, accumulation and toxicokinetics of aluminum in some tissues of male albino rats.
    Rawy SM; Morsy GM; Elshibani MM
    Toxicol Ind Health; 2013 Apr; 29(3):254-63. PubMed ID: 22317823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.